Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,158,000 | 31,407,000 | 22,025,000 | 9,195,000 | 16,056,000 |
| Depreciation Amortization | 6,290,000 | 5,064,000 | 5,191,000 | 4,681,000 | 5,755,000 |
| Income taxes - deferred | -3,442,000 | -3,764,000 | -4,636,000 | 2,288,000 | 561,000 |
| Accounts receivable | 347,000 | 261,000 | -3,811,000 | -1,275,000 | -1,124,000 |
| Other Working Capital | -2,172,000 | -5,639,000 | 12,804,000 | -307,000 | -3,902,000 |
| Other Operating Activity | 5,519,000 | 1,938,000 | 1,007,000 | -179,000 | -4,758,000 |
| Operating Cash Flow | $8,700,000 | $29,267,000 | $32,580,000 | $14,403,000 | $12,588,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,464,000 | 7,954,000 | -19,098,000 | -1,798,000 | 9,273,000 |
| PPE Investments | -3,907,000 | -3,236,000 | -2,711,000 | -2,226,000 | -2,046,000 |
| Net Acquisitions | -43,430,000 | -22,997,000 | N/A | N/A | -10,861,000 |
| Purchase Of Investment | -204,000 | -1,913,000 | -1,068,000 | -597,000 | -201,000 |
| Sale Of Investment | 1,979,000 | 641,000 | 649,000 | 723,000 | 232,000 |
| Other Investing Activity | -180,000 | 3,768,000 | -318,000 | -373,000 | -342,000 |
| Investing Cash Flow | $-32,278,000 | $-15,783,000 | $-22,546,000 | $-4,271,000 | $-3,945,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,686,000 | 3,669,000 | -96,000 | 8,223,000 | 19,006,000 |
| Debt Issued | 30,831,000 | 0 | 997,000 | 5,222,000 | 4,942,000 |
| Debt Repayment | -2,569,000 | -3,298,000 | -2,004,000 | -4,003,000 | -6,806,000 |
| Common Stock Repurchased | 0 | -2,000,000 | 0 | 0 | -8,865,000 |
| Dividend Paid | -9,247,000 | -8,983,000 | -8,729,000 | -8,440,000 | -8,043,000 |
| Other Financing Activity | -635,000 | -4,222,000 | 16,000 | -10,651,000 | -8,719,000 |
| Financing Cash Flow | $26,066,000 | $-14,834,000 | $-9,816,000 | $-9,649,000 | $-8,485,000 |
| Exchange Rate Effect | -40,000 | -165,000 | -59,000 | -8,000 | -32,000 |
| Beginning Cash Position | 468,000 | 1,983,000 | 1,825,000 | 1,350,000 | 1,225,000 |
| End Cash Position | 2,917,000 | 468,000 | 1,983,000 | 1,825,000 | 1,350,000 |
| Net Cash Flow | $2,448,000 | $-1,515,000 | $159,000 | $475,000 | $125,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,700,000 | 29,267,000 | 32,580,000 | 14,403,000 | 12,588,000 |
| Capital Expenditure | -3,907,000 | -3,236,000 | -2,711,000 | -2,226,000 | -2,046,000 |
| Free Cash Flow | 4,793,000 | 26,031,000 | 29,869,000 | 12,177,000 | 10,542,000 |